PPARGC1A and neoplasm: The effector mechanism of PGC‐1α to reprogram cellular metabolism by promoting mitochondrial metabolism in response to external stressors makes it a plausible mediator of therapy‐resistance and tumour cell survival and therefore a promising target for therapeutic intervention.